We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmaker Presses VA to Use Emergency Power to Reduce Price of Gilead’s Sovaldi
Lawmaker Presses VA to Use Emergency Power to Reduce Price of Gilead’s Sovaldi
The former chairman of the Senate Veterans Affairs Committee is pressing the VA to invoke a wartime provision to break the patents on Gilead Sciences’ pricey hepatitis C drug Sovaldi, after the agency stopped treating veterans because it had exceeded the more than $400 million budgeted for hep C treatment.